Clinical Trials for Systemic Sclerosis With Lung Involvement

Find clinical trials for systemic sclerosis with lung involvement. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

NCT ID: NCT05785624

This clinical trial is studying a new medication called vixarelimab to see how well it works and how safe it is for people with two specific lung diseases: idiopathic pulmonary fibrosis (IPF) and s...

Recruiting

Phase: PHASE2 Type: interventional Locations: Kansas City, Kansas, United States, Houston, Texas, United States +143 more

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

NCT ID: NCT05785065

This clinical trial is studying the effectiveness of a medication called mycophenolate mofetil in people with systemic sclerosis (a condition that affects the skin and internal organs) who also hav...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hamilton, Ontario, Canada, Montreal, Quebec, Canada +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions